Critical Care · 2001 · 10 citations · 15 references
MedicineNeurologyPharmacotherapyClinical PharmacologyAcute Ischemic StrokeAcute Stroke ManagementCerebrovascular DiseaseStrokeAcute Ischemic Stroke InterventionAcute Ischemic Stroke ManagementAcute Ischemic Stroke TreatmentCerebral Ischemia PharmacotherapyHigh-flow Nasal Cannula Oxygen Therapy
In the past, high-molecular weight, highly substituted hydroxyethyl starch (HES) 450/0.7, which is mostly used in the United States, has been implicated in bleeding complications, some of them lethal. In Europe, medium-molecular weight HES with a low degree of substitution (0.5) has been preferred. The present study investigated, whether a long-term, high-dose volume therapy with a newly developed 6% HES 130/0.4 (Voluven ® ) is safe in patients suffering from acute ischemic stroke. In particular, the effects on hemostaseology were examined.
15
Prognosis in Acute Organ-System Failure
William A. Knaus, Elizabeth A. Draper, Douglas P. Wagner et al. · Annals of Surgery · 1985 · 1.2K citations
Withholding and Withdrawal of Life Support from the Critically Ill
Nicholas G. Smedira, Bradley H. Evans, Linda S. Grais et al. · New England Journal of Medicine · 1990 · 619 citations · Full text
The effect of acute renal failure on mortality. A cohort analysis
E. M. Levy · JAMA · 1996 · 442 citations